众生药业：8月27日召开董事会会议

Group 1 - The core point of the article is that Zhongsheng Pharmaceutical (SZ 002317) held its 26th meeting of the 8th Board of Directors on August 27, 2025, to review the 2025 semi-annual report and summary [1] - For the year 2024, the revenue composition of Zhongsheng Pharmaceutical is as follows: pharmaceutical manufacturing accounts for 94.93%, pharmaceutical trade accounts for 4.13%, and other businesses account for 0.95% [1] - As of the time of reporting, Zhongsheng Pharmaceutical has a market capitalization of 18.1 billion yuan [1]